Shankar Raman, MD,MPH Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 8200 Stockdale Hwy Ste M10-173, Bakersfield, CA 93311 Phone: 661-632-6963 Fax: 661-864-1105 |
Dr. Carlos Miguel D'assumpcao, MD Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 1700 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-326-2202 Fax: 661-326-2950 |
Soe Soe Win, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2531 Chester Ave, Bakersfield, CA 93301 Phone: 661-337-7108 Fax: 661-337-7253 |
Dr. Anthony Milanes, M.D. Internal Medicine - Infectious Disease Medicare: Medicare Enrolled Practice Location: 4570 California Ave, Bakersfield, CA 93309 Phone: 213-446-0459 |
Randolph Del Castillo Senining, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 6501 Truxtun Ave, Bakersfield, CA 93309 Phone: 661-322-2206 Fax: 661-327-7027 |
Dr. Rasha A Kuran, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2828 H St, Ste A, Bakersfield, CA 93301 Phone: 661-322-9200 Fax: 661-322-9201 |
Dr. Arash Heidari, M.D Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 3838 San Dimas St Ste A100, Bakersfield, CA 93301 Phone: 661-327-8538 Fax: 661-327-5432 |
News Archive
A frightening electrical injury to an operating room nurse highlights the need to update electrical safety policies for the operating room, according to the June issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Biologists on the Florida campus of The Scripps Research Institute have discovered a new mechanism that likely underlies how we feel force or touch. Their study suggests that "rafts" of fatty lipids on the cell surface act as compartments to keep certain enzymes from mixing with their binding partners.
Genentech, Inc., a wholly owned member of the Roche Group, and Biogen Idec today announced that three-year follow up of the pivotal Phase III CLL8 trial showed Rituxan plus fludarabine and cyclophosphamide (FC) chemotherapy helped patients in the trial with previously untreated chronic lymphocytic leukemia (CLL) live longer than FC alone.
GlobalPost's "Global Pulse" blog examines how Kenya is working to decrease the number of preventable deaths under a "recently launched ... campaign called 'Let's Live,' which sets a target of reducing preventable deaths in Kenya by 50 percent by December 2012."
› Verified 7 days ago